SOX2 and breast carcinoma: Furthermore, tangeretin exhibits the potential to inhibit the formation of breast cancer stem cells (BCSCs) by acting on the Stat3/Sox2 signaling pathway, offering a potential therapeutic strategy for breast cancer and BCSCs [36].